Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

South Texas Accelerated Research Therapeutics

InstitutionResearch output, impact & collaborations

South Texas Accelerated Research Therapeutics is a research organisation in San Antonio, US. OpenAlex records 1,533 works and 119,176 citations for it. 224 researchers list it as their most recent affiliation.

1,533
Works
119,176
Citations
224
Researchers
71
Avg h-index

How has South Texas Accelerated Research Therapeutics's publication output changed over time?

ScholarIQpublication output · 2012–2024

Output grew0% over the shown period — from 1 works in 2012 to 1 in 2024.

1
1
2
1
1
1
201220152016201720232024

What are the most-cited papers on South Texas Accelerated Research Therapeutics?

ScholarIQmost cited works
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi
New England Journal of Medicine. 20156,267 CitationsOPEN ACCESS
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik, Lee S. Rosen, Sara M. Tolaney, Anthony W. Tolcher, Jonathan W. Goldman, Leena Gandhi, Kyriakos P. Papadopoulos, Muralidhar Beeram, Drew Rasco, John Hilton, Aejaz Nasir, Richard P. Beckmann, Andrew E. Schade, Angie D. Fulford, Tuan S. Nguyen, Ricardo Martínez, Palaniappan Kulanthaivel, Lily Q. Li, Martin Frenzel, Damien M. Cronier, Edward M. Chan, Keith T. Flaherty, Patrick Y. Wen, Geoffrey I. Shapiro
Cancer Discovery. 2016764 CitationsOPEN ACCESS
Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Anthony W. Tolcher, Wells A. Messersmith, Stanislaw M. Mikulski, Kyriakos P. Papadopoulos, Eunice L. Kwak, Darlene Gibbon, Amita Patnaik, Gerald S. Falchook, Arvind Dasari, Geoffrey I. Shapiro, John F. Boylan, Zhi-Xin Xu, Ka Wang, Astrid Koehler, James Song, Steven A. Middleton, Jonathan Deutsch, Mark DeMario, Razelle Kurzrock, Jennifer J. Wheler
Journal of Clinical Oncology. 2012280 CitationsOPEN ACCESS
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
Amita Patnaik, Leonard J. Appleman, Anthony W. Tolcher, Kyriakos P. Papadopoulos, Muralidhar Beeram, Drew Rasco, Glen J. Weiss, Jasgit C. Sachdev, Manpreet Chadha, Maddie Fulk, Samuel Ejadi, James M. Mountz, Michael T. Lotze, Frederico G. S. Toledo, Edward Chu, Michael Jeffers, Carol E. Peña, Chenjing Xia, Stefanie Reif, Isabelle Genvresse, Ramesh K. Ramanathan
Annals of Oncology. 2016237 CitationsOPEN ACCESS
First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors
Kyriakos P. Papadopoulos, Larry Gluck, Lainie P. Martin, Anthony J. Olszanski, Anthony W. Tolcher, Gataree Ngarmchamnanrith, Erik Rasmussen, Benny Amore, Dirk Nagorsen, John S. Hill, Joe Stephenson
Clinical Cancer Research. 2017211 Citations

Who collaborates most closely around South Texas Accelerated Research Therapeutics?

ScholarIQco-authorship network
United States
100%

MOST FREQUENT PARTNER INSTITUTIONS

How much of the research on South Texas Accelerated Research Therapeutics is open access?

ScholarIQopen access share
86%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
29%
Bronze
57%
Closed
14%

Related on ScholarIQ

Cancer Immunotherapy and Biomarkers
Top Topic
HER2/EGFR in Cancer Research
Top Topic
Lung Cancer Treatments and Mutations
Top Topic
Monoclonal and Polyclonal Antibodies Research
Top Topic
CAR-T cell therapy research
Top Topic
Advanced Breast Cancer Therapies
Top Topic
470M+ articles · free account